Clinical Trials on Viral Hepatitis in Norway

Total 126 results

Haukeland University Hospital
Hoffmann-La Roche; Bergen Prison, Norwegian Correctional Service

Terminated

Hepatitis C Treatment of Inmates (PEGPRI)

Chronic Hepatitis C

Norway
Ullevaal University Hospital
Schering-Plough

Completed

14 vs 24 Weeks HCV Treatment to Genotype 2/3 Patients With Rapid Virological Response

Hepatitis C Virus Infection

Norway
Haukeland University Hospital
University of Bergen

Unknown

Liver Elastography in Patients Undergoing Treatment for Hepatitis C

Hepatitis C Virus Infection

Norway
Sorlandet Hospital HF

Completed

HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group.

Hepatitis | Opiate Dependence

Norway
Haukeland University Hospital
University of Bergen; Helse Stavanger HF; Helse Vest; Forskningsrådet; Folkehelse... and other collaborators

Active, not recruiting

Integrated Treatment of Hepatitis C Virus Infection (INTRO-HCV)

Hepatitis C, Chronic | Opioid Dependence, on Agonist Therapy

Norway
Oslo University Hospital
Karolinska University Hospital; Hvidovre University Hospital; Addis Ababa University and other collaborators

Completed

The Norwegian Nucleoside Analogue Stop Study (Nuc-Stop)

Hepatitis B, Chronic

Norway, Denmark, Ethiopia, Sweden
University Hospital, Akershus

Completed

Opportunstic Hepatitis C Virus Treatment (Opportuni-C)

Hepatitis C | Substance Use Disorders

Norway
University Hospital, Akershus

Unknown

HCV Treatment in a Low-threshold Clinic (Prindsen)

Hepatitis C | Substance Use Disorders

Norway
Kirby Institute
Merck Sharp & Dohme LLC

Completed

A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3 (ACTIVATE)

Hepatitis C, Chronic

Australia, Canada, United Kingdom, Belgium, Germany, Norway, Switzerland
Sorlandet Hospital HF

Recruiting

Non-invasive Diagnostics of Microbial Keratitis

Infectious Keratitis

Norway
Diakonhjemmet Hospital
University Hospital, Akershus

Active, not recruiting

Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication (Nor-vaC)

Rheumatoid Arthritis | Crohn Disease | Ulcerative Colitis | Autoimmune Hepatitis | Psoriatic Arthritis | Liver Transplant; Complications | Spondyloarthritis

Norway
Eiger BioPharmaceuticals

Completed

Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a (D-LIVR)

Hepatitis Delta Virus

United States, Belgium, Spain, Greece, Canada, Italy, Romania, Germany, Israel, Bulgaria, Taiwan, Turkey, Pakistan, Sweden, Ukraine, New Zealand, Russian Federation, United Kingdom, Moldova, Republic of, France, Mongolia, Switzerland
Kirby Institute
National Health and Medical Research Council, Australia

Recruiting

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings (ETHOS II)

Hepatitis C

Australia
Tibotec Pharmaceuticals, Ireland

Completed

A Study of TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment (PILLAR)

Hepatitis C

United States, Australia, France, Belgium, Germany, Spain, Denmark, Canada, New Zealand, Russian Federation, Austria, Poland, Norway
Kirby Institute

Recruiting

Australian Hepatitis and Risk Survey in Prisons (AusHep)

HIV Infections | Hepatitis B | Hepatitis C

Australia
Tibotec Pharmaceuticals, Ireland

Completed

A Safety and Effectiveness Study of TMC435 in Chronic, Genotype 1, Hepatitis C Patients Who Failed to Previous Standard Treatment (ASPIRE)

Hepatitis C

United States, Australia, France, United Kingdom, Belgium, Germany, Israel, Portugal, Canada, New Zealand, Russian Federation, Austria, Poland, Norway
GlaxoSmithKline

Completed

Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Sweden, Norway
Boehringer Ingelheim

Completed

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Hepatitis C, Chronic

United States, Austria, Canada, France, Germany, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Russian Federation, Spain, United Kingdom
Boehringer Ingelheim

Completed

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2)

Hepatitis C

United States, Canada, Korea, Republic of, Puerto Rico, Taiwan
AbbVie

Completed

A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (TOPAZ-I)

Chronic Hepatitis C Virus (HCV) Infection Genotype 1

Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
Janssen R&D Ireland

Completed

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy (ATTAIN)

Hepatitis C

United States, Australia, France, Poland, United Kingdom, Germany, Spain, Belgium, Israel, Portugal, Bulgaria, Romania, Denmark, Greece, Sweden, Canada, Czech Republic, Argentina, Brazil, Austria, Hungary, Switzerland, Puerto Rico, No...
University of Bergen
Norwegian University of Science and Technology; International Centre for Diarrhoeal...

Active, not recruiting

An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh (FluEffect)

Influenza Viral Infections

Bangladesh, Norway
Helse Stavanger HF
Tor Paaske Utheim; Vegard Asgeir Forsaa; Vilde Marie Thomseth

Enrolling by invitation

Epidemiological Study of Dry Eye Disease in Stavanger: Dry Eye Disease in Patients Treated With Intravitreal Injections (EPISTA1)

Dry Eye

Norway
Nykode Therapeutics ASA
Vaccibody AS

Completed

A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers

Infections | COVID-19 | Infection Viral

Norway
Oslo University Hospital
Schepens Eye Research Institute; The Norwegian Dry Eye Clinic

Completed

Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction

Dry Eye Syndromes | Meibomian Gland Dysfunction

Norway
The Norwegian Dry Eye Clinic
Laboratoires Thea

Recruiting

Comparison of Two Types of Artificial Tears

Dry Eye Disease

Norway
University Hospital, Akershus
Vestre Viken Hospital Trust; Norwegian Institute of Public Health; Oslo University... and other collaborators

Recruiting

COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology

COVID | Pediatric Respiratory Diseases | Fatigue Post Viral

Norway
Ifocus Oyeklinikk
The Research Council of Norway

Recruiting

Metabolomic Profile in Dry Eye Syndrome Patients.

Cataract | Dry Eye Syndromes

Norway
Lovisenberg Diakonale Hospital
University of Oslo; Oslo University Hospital; Icahn School of Medicine at Mount... and other collaborators

Recruiting

Cognitive Rehabilitation in Post-COVID-19 Condition (TRAINCOVID)

COVID-19

Norway
Norwegian University of Science and Technology
University of Oslo

Active, not recruiting

Use of E-health Based Exercise Intervention After COVID-19

COVID-19

Norway
Oslo University Hospital

Completed

Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital (CovidRegOUH)

COVID-19

Norway
Norwegian Institute of Public Health
University of Basel

Recruiting

Glasses Against Transmission of SARS-CoV-2 (COVID-19) in the Community (GLASSY)

Respiratory Tract Infections | COVID-19

Norway
Norwegian Institute of Public Health
City of Oslo, Norway

Recruiting

Conversation With Family Doctor to Increase COVID-19 Vaccine Uptake

COVID-19

Norway
Norwegian Institute of Public Health
The National Institute of Occupational Health, Norway

Recruiting

The Effect of Working at Home to Reduce Risk of Respiratory Infection

Respiratory Tract Infections | COVID-19

Norway
University of Bergen
Haukeland University Hospital

Recruiting

Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination (COVID19vac-1)

Covid19

Norway
University Hospital, Akershus

Completed

Long-term Effects of COVID-19 in Adolescents (LoTECA)

Covid19

Norway
Norwegian Institute of Public Health
Stovner District, City of Oslo, Norway

Completed

COVID-19: The Effectiveness of Free Face Mask Distribution

Covid19

Norway
Lars Wik
Oslo University Hospital; University of the Basque Country (UPV/EHU); University... and other collaborators

Completed

Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation (HSC19)

COVID 19

Norway
University Hospital, Akershus

Unknown

Mechanisms for Covid-19 Disease Complications (COVID MECH)

Coronavirus Infection | COVID

Norway
Oslo University Hospital
University of Oslo; Norwegian Institute of Public Health

Completed

Cod Liver Oil for Covid-19 Prevention Study

Respiratory Tract Infections | Covid-19

Norway
Haukeland University Hospital

Completed

COVID-19 - No Health Without Mental Health (Co-COVID-19)

Covid19 | Anxiety

Norway
Oslo University Hospital

Completed

The COVID-ICU Healthcare Professional Study

COVID-19 | Critical Care | Intensive Care Units | Health Personnel

Norway
Oslo University Hospital
Eurocine Vaccines AB; Bionor Immuno AS

Completed

Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant

HIV Infection

Norway
Sykehuset Telemark
Norwegian Institute of Public Health; Oslo University Hospital; Sorlandet Hospital... and other collaborators

Recruiting

The Norwegian Tick Born Encephalitis Study (NOTES)

Tick-Borne Encephalitis, European

Norway
University Hospital, Akershus

Active, not recruiting

Norwegian Coronavirus Disease 2019 Study (NO COVID-19)

Corona Virus Infection

Norway
Oslo Metropolitan University
Norwegian Institute of Public Health

Active, not recruiting

Assocation Between In-person Instruction and COVID-19 Risk (Campus&Corona)

Infection | Infection Control

Norway
University Hospital, Akershus
Oslo University Hospital; Ostfold Hospital Trust; Haukeland University Hospital; St. Olavs Hospital and other collaborators

Unknown

Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19 (PROLUN)

Covid19 | Lung Function Decreased

Norway
Oslo University Hospital
European Organisation for Research and Treatment of Cancer - EORTC; University... and other collaborators

Completed

Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ

Covid19, Patient Reported Outcome Measures, Quality of Life

Norway
Oslo University Hospital
University of Oslo

Completed

Improving Prognosis in HIV Infection

Human Immunodeficiency Virus

Norway
University of Oslo
University of Bergen; Modum Bad; Oslo Metropolitan University

Completed

Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety

Depression | Anxiety | Parental Stress

Norway

Clinical Trials on Viral Hepatitis in Norway

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations